BDBM571590 (1R,3S,5R)-5-(2- azaspiro[3,4]octan-2- ylmethyl)-2-(2-(3-acetyl-7- methyl-1H-indazol-1- yl)acetyl)-N-(6-bromo-3- methylpyridin-2-yl)-2- azabicyclo[3.1.0]hexane-3- carboxamide::US11447465, Cmp No. T-42

SMILES CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(CN3CC4(C3)CCCC4)C[C@H]2C(=O)Nc2nc(Br)ccc2C)c2c(C)cccc12

InChI Key InChIKey=CHEFWGUMNNDKKN-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 571590   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM571590((1R,3S,5R)-5-(2- azaspiro[3,4]octan-2- ylmethyl)-2...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent